(Q30440344)

18 August 2017

Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population (English)

1 reference

cost-effectiveness analysis

18 August 2017

1 reference

1 reference

Susan G Moore

1

1 reference

18 August 2017

Pareen J Shenoy

2

1 reference

18 August 2017

Laura Fanucchi

3

1 reference

18 August 2017

John W Tumeh

4

1 reference

18 August 2017

Christopher R Flowers

5

1 reference

18 August 2017

language of work or name

1 reference

13 January 2009

1 reference

BMC Health Services Research

18 August 2017

1 reference

18 August 2017

9

1 reference

18 August 2017

9

1 reference

Practical approach for using Medicare data to estimate costs for cost-effectiveness analysis

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

20 June 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

Breast MRI as a screening tool: the appropriate role

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

Effect of screening and adjuvant therapy on mortality from breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

United States life tables, 2002.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

A fair approach to discounting future effects: taking a societal perspective.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2630922

Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.

20 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-9-9

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-9-9

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-9-9

Mammography screening for older women with and without cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-9-9

Cost-effectiveness analysis of breast cancer adjuvant treatment: FEC 50 versus FEC 100 (FASG05 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-9-9

Possible consequences of applying guidelines to healthy women with a family history of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-9-9

Breast cancer screening and diagnosis

21 January 2018

1 reference

12 December 2020

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

12 December 2020

Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality

1 reference

12 December 2020

Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy

1 reference

12 December 2020

The impact of a breast cancer screening programme on quality-adjusted life-years

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6963-9-9

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference

18 August 2017

PubMed publication ID

19144138

1 reference